Report Detail
Global Indolent Lymphoma Treatment Market Size, Status and Forecast 2019-2025
- RnM3467395 |
- 08 July, 2019 |
- Global |
- 90 Pages |
- QYResearch |
- Other
Indolent Lymphoma also known as non-Hodgkin’s lymphoma is a type of cancer that initiates from cells of immune system which are responsible to fight against infections and diseases encountered by our body. Lymphatic system is a part of the immune system and has network of lymph vessels in the body thus lymphoma can initiate anywhere.
ndolent lymphoma treatment is most common cancer observed in the lymphatic system and can be treated successfully. The factors which contribute to drive the indolent lymphoma market are geriatric population and lifestyle. In today’s world people have addictions to alcohol, tobacco and drugs, obesity is one of the major cause of various disorders thus the risks for such disorders are high. The mortality ratio is quite low as compared to treatment facilities available a few years back. Clinical approvals and safety regulations laid by FDA and regulatory bodies are some restraints for this market, but many other drugs are into clinical trials and will soon be available for use.
In 2018, the global Indolent Lymphoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Indolent Lymphoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Indolent Lymphoma Treatment development in United States, Europe and China.
The key players covered in this study
Altor BioScience Corporation
Amgen Inc.
Astellas Pharma Inc.
Bayer AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences
Incyte Corporation
Infinity Pharmaceuticals
Juno Therapeutics Inc.
MedImmune
Market segment by Type, the product can be split into
BI-836826
ALT-803
BMS-986016
CC-122
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Indolent Lymphoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Indolent Lymphoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Indolent Lymphoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Indolent Lymphoma Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 BI-836826
- 1.4.3 ALT-803
- 1.4.4 BMS-986016
- 1.4.5 CC-122
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Indolent Lymphoma Treatment Market Share by Application (2014-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Indolent Lymphoma Treatment Market Size
- 2.2 Indolent Lymphoma Treatment Growth Trends by Regions
- 2.2.1 Indolent Lymphoma Treatment Market Size by Regions (2014-2025)
- 2.2.2 Indolent Lymphoma Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Indolent Lymphoma Treatment Market Size by Manufacturers
- 3.1.1 Global Indolent Lymphoma Treatment Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Indolent Lymphoma Treatment Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Indolent Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Indolent Lymphoma Treatment Key Players Head office and Area Served
- 3.3 Key Players Indolent Lymphoma Treatment Product/Solution/Service
- 3.4 Date of Enter into Indolent Lymphoma Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Indolent Lymphoma Treatment Market Size by Type (2014-2019)
- 4.2 Global Indolent Lymphoma Treatment Market Size by Application (2014-2019)
5 United States
- 5.1 United States Indolent Lymphoma Treatment Market Size (2014-2019)
- 5.2 Indolent Lymphoma Treatment Key Players in United States
- 5.3 United States Indolent Lymphoma Treatment Market Size by Type
- 5.4 United States Indolent Lymphoma Treatment Market Size by Application
6 Europe
- 6.1 Europe Indolent Lymphoma Treatment Market Size (2014-2019)
- 6.2 Indolent Lymphoma Treatment Key Players in Europe
- 6.3 Europe Indolent Lymphoma Treatment Market Size by Type
- 6.4 Europe Indolent Lymphoma Treatment Market Size by Application
7 China
- 7.1 China Indolent Lymphoma Treatment Market Size (2014-2019)
- 7.2 Indolent Lymphoma Treatment Key Players in China
- 7.3 China Indolent Lymphoma Treatment Market Size by Type
- 7.4 China Indolent Lymphoma Treatment Market Size by Application
8 Japan
- 8.1 Japan Indolent Lymphoma Treatment Market Size (2014-2019)
- 8.2 Indolent Lymphoma Treatment Key Players in Japan
- 8.3 Japan Indolent Lymphoma Treatment Market Size by Type
- 8.4 Japan Indolent Lymphoma Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Indolent Lymphoma Treatment Market Size (2014-2019)
- 9.2 Indolent Lymphoma Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Indolent Lymphoma Treatment Market Size by Type
- 9.4 Southeast Asia Indolent Lymphoma Treatment Market Size by Application
10 India
- 10.1 India Indolent Lymphoma Treatment Market Size (2014-2019)
- 10.2 Indolent Lymphoma Treatment Key Players in India
- 10.3 India Indolent Lymphoma Treatment Market Size by Type
- 10.4 India Indolent Lymphoma Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Indolent Lymphoma Treatment Market Size (2014-2019)
- 11.2 Indolent Lymphoma Treatment Key Players in Central & South America
- 11.3 Central & South America Indolent Lymphoma Treatment Market Size by Type
- 11.4 Central & South America Indolent Lymphoma Treatment Market Size by Application
12 International Players Profiles
- 12.1 Altor BioScience Corporation
- 12.1.1 Altor BioScience Corporation Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Indolent Lymphoma Treatment Introduction
- 12.1.4 Altor BioScience Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.1.5 Altor BioScience Corporation Recent Development
- 12.2 Amgen Inc.
- 12.2.1 Amgen Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Indolent Lymphoma Treatment Introduction
- 12.2.4 Amgen Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.2.5 Amgen Inc. Recent Development
- 12.3 Astellas Pharma Inc.
- 12.3.1 Astellas Pharma Inc. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Indolent Lymphoma Treatment Introduction
- 12.3.4 Astellas Pharma Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.3.5 Astellas Pharma Inc. Recent Development
- 12.4 Bayer AG
- 12.4.1 Bayer AG Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Indolent Lymphoma Treatment Introduction
- 12.4.4 Bayer AG Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.4.5 Bayer AG Recent Development
- 12.5 Boehringer Ingelheim GmbH
- 12.5.1 Boehringer Ingelheim GmbH Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Indolent Lymphoma Treatment Introduction
- 12.5.4 Boehringer Ingelheim GmbH Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.5.5 Boehringer Ingelheim GmbH Recent Development
- 12.6 Bristol-Myers Squibb Company
- 12.6.1 Bristol-Myers Squibb Company Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Indolent Lymphoma Treatment Introduction
- 12.6.4 Bristol-Myers Squibb Company Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.6.5 Bristol-Myers Squibb Company Recent Development
- 12.7 Celgene Corporation
- 12.7.1 Celgene Corporation Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Indolent Lymphoma Treatment Introduction
- 12.7.4 Celgene Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.7.5 Celgene Corporation Recent Development
- 12.8 Eli Lilly and Company
- 12.8.1 Eli Lilly and Company Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Indolent Lymphoma Treatment Introduction
- 12.8.4 Eli Lilly and Company Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.8.5 Eli Lilly and Company Recent Development
- 12.9 F. Hoffmann-La Roche Ltd.
- 12.9.1 F. Hoffmann-La Roche Ltd. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Indolent Lymphoma Treatment Introduction
- 12.9.4 F. Hoffmann-La Roche Ltd. Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.9.5 F. Hoffmann-La Roche Ltd. Recent Development
- 12.10 Gilead Sciences
- 12.10.1 Gilead Sciences Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Indolent Lymphoma Treatment Introduction
- 12.10.4 Gilead Sciences Revenue in Indolent Lymphoma Treatment Business (2014-2019)
- 12.10.5 Gilead Sciences Recent Development
- 12.11 Incyte Corporation
- 12.12 Infinity Pharmaceuticals
- 12.13 Juno Therapeutics Inc.
- 12.14 MedImmune
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Indolent Lymphoma Treatment. Industry analysis & Market Report on Indolent Lymphoma Treatment is a syndicated market report, published as Global Indolent Lymphoma Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Indolent Lymphoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
